Project Management in Drug Development: Phase III and Commercialization
Training Overview
Improve Your Ability to:
- Practice cross-functional project management in late-stage clinical development and commercialization
- Ensure project success through formation of a cohesive, cross-functional project team
- Communicate with internal and external stakeholders and avoid communication breakdowns that can lead to project delays
- Effectively prioritize key features and attributes of your end-product through successful creation and management of your Target Product Profiles (TPPs)
- Develop project objectives and a project plan to keep team members well organized and on target
- Implement, monitor and control projects in Phase III and Commercialization to enable an on-time, on-budget product launch
- Apply risk management strategies when establishing project objectives and make risk-based decisions
- Develop and follow a Work Breakdown Structure for Phase III, commercialization and Phase IV activities to help ensure that the project team works as a cohesive unit
- Transition successfully from Phase III to the market and avoid costly delays
- Develop a realistic timeline to help track your progress against set objectives and save valuable time
Institute for International Research (IIR) is a Project Management Institute (PMI®) Registered Education Provider (R.E.P.). IIR is committed to enhancing the ongoing professional development of PMI Members, PMI-certified Project Management Professionals (PMP®) and other project management stakeholders through appropriate project management learning activities and products. As a PMI R.E.P., Institute for International Research has agreed to abide by PMI established operational and educational criteria, and is subject to random audits for quality assurance purposes.
PTi international is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmaceutical education. Participants will receive a maximum of 14 hours (1.4 CEUs) of continuing education credit for full participation in the two-day training. ACPE # 326-000-06-159-L04, Initial release: 07/2006.